Table of Content

1 Neuroendocrine Tumor Drug Market Introduction and Overview
1.1 Neuroendocrine Tumor Drug Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Neuroendocrine Tumor Drug Industry Dynamic Analysis
1.5.1 Neuroendocrine Tumor Drug Market Trends Analysis
1.5.2 Neuroendocrine Tumor Drug Market Drivers Analysis
1.5.3 Neuroendocrine Tumor Drug Market Challenges Analysis
1.5.4 Neuroendocrine Tumor Drug Market Restraints Analysis
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
1.8 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Neuroendocrine Tumor Drug Market Insights by Type
2.1 Market Size Insights by Types
2.2 Global Neuroendocrine Tumor Drug Revenue and Share by Type
3 Global Neuroendocrine Tumor Drug Market Insights by Application
3.1 Market Size Insights by Application
3.2 Global Neuroendocrine Tumor Drug Revenue and Share by Application (2019-2024)
4 Global Market Growth Insights
4.1 Global Neuroendocrine Tumor Drug Market Size (2019-2024)
4.2 Neuroendocrine Tumor Drug Growth Insights by Regions
4.2.1 Neuroendocrine Tumor Drug Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Neuroendocrine Tumor Drug Revenue Market Size by Regions (2019-2024)
4.2.3 North America Neuroendocrine Tumor Drug Market Size (2019-2024)
4.2.4 Europe Neuroendocrine Tumor Drug Market Size (2019-2024)
4.2.5 Asia-Pacific Neuroendocrine Tumor Drug Market Size (2019-2024)
4.2.6 Latin America Neuroendocrine Tumor Drug Market Size (2019-2024)
4.2.7 Middle East & Africa Neuroendocrine Tumor Drug Market Size (2019-2024)
5 North America
5.1 North America Neuroendocrine Tumor Drug Revenue by Countries
5.1.1 North America Neuroendocrine Tumor Drug Revenue by Countries (2019-2024)
5.2 North America PEST Analysis
5.3 United States
5.4 Canada
6 Asia Pacific
6.1 Asia Pacific Neuroendocrine Tumor Drug Revenue by Countries
6.1.1 Asia Pacific Neuroendocrine Tumor Drug Revenue by Countries (2019-2024)
6.2 Asia-Pacific PEST Analysis
6.3 China
6.4 Japan
6.5 Korea
6.6 Southeast Asia
6.7 India
6.8 Australia
7 Europe
7.1 Europe Neuroendocrine Tumor Drug Revenue by Countries
7.1.1 Europe Neuroendocrine Tumor Drug Revenue by Countries (2019-2024)
7.2 Europe PEST Analysis
7.3 Germany
7.4 France
7.5 UK
7.6 Italy
7.7 Russia
7.8 Spain
7.9 Nordic
8 Latin America
8.1 Latin America Neuroendocrine Tumor Drug Revenue by Countries
8.1.1 Latin America Neuroendocrine Tumor Drug Revenue by Countries (2019-2024)
8.2 Latin America PEST Analysis
8.3 Brazil
8.4 Argentina
8.5 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Neuroendocrine Tumor Drug Revenue by Countries
9.1.1 Middle East & Africa Neuroendocrine Tumor Drug Revenue by Countries (2019-2024)
9.2 Middle East & Africa PEST Analysis
9.3 Egypt
9.4 South Africa
9.5 UAE
9.6 Turkey
9.7 Saudi Arabia
10 Global Neuroendocrine Tumor Drug Market Competition, by Players
10.1 Global Neuroendocrine Tumor Drug Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Neuroendocrine Tumor Drug Players Market Share in 2023
10.2.2 Top 6 Neuroendocrine Tumor Drug Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Neuroendocrine Tumor Drug Players Head Office, Business Provided
10.4 Neuroendocrine Tumor Drug Mergers & Acquisitions
10.5 Neuroendocrine Tumor Drug New Entrants and Expansion Plans
11 Players Profiles
11.1 Eisai
11.1.1 Eisai Company Profile
11.1.2 Neuroendocrine Tumor Drug Product Overview
11.1.3 Eisai Neuroendocrine Tumor Drug Market Performance (2019-2024)
11.1.4 Eisai Business Overview
11.1.5 Recent Developments and Plans
11.2 Exelixis Inc.
11.2.1 Exelixis Inc. Company Profile
11.2.2 Neuroendocrine Tumor Drug Product Overview
11.2.3 Exelixis Inc. Neuroendocrine Tumor Drug Market Performance (2019-2024)
11.2.4 Exelixis Inc. Business Overview
11.2.5 Recent Developments and Plans
11.3 Foresee Pharmaceuticals LLC
11.3.1 Foresee Pharmaceuticals LLC Company Profile
11.3.2 Neuroendocrine Tumor Drug Product Overview
11.3.3 Foresee Pharmaceuticals LLC Neuroendocrine Tumor Drug Market Performance (2019-2024)
11.3.4 Foresee Pharmaceuticals LLC Business Overview
11.3.5 Recent Developments and Plans
11.4 Hutchison MediPharma Limited
11.4.1 Hutchison MediPharma Limited Company Profile
11.4.2 Neuroendocrine Tumor Drug Product Overview
11.4.3 Hutchison MediPharma Limited Neuroendocrine Tumor Drug Market Performance (2019-2024)
11.4.4 Hutchison MediPharma Limited Business Overview
11.4.5 Recent Developments and Plans
11.5 Intezyne Inc
11.5.1 Intezyne Inc Company Profile
11.5.2 Neuroendocrine Tumor Drug Product Overview
11.5.3 Intezyne Inc Neuroendocrine Tumor Drug Market Performance (2019-2024)
11.5.4 Intezyne Inc Business Overview
11.5.5 Recent Developments and Plans
11.6 INVENT Pharmaceuticals Inc.
11.6.1 INVENT Pharmaceuticals Inc. Company Profile
11.6.2 Neuroendocrine Tumor Drug Product Overview
11.6.3 INVENT Pharmaceuticals Inc. Neuroendocrine Tumor Drug Market Performance (2019-2024)
11.6.4 INVENT Pharmaceuticals Inc. Business Overview
11.6.5 Recent Developments and Plans
11.7 Ipsen S.A.
11.7.1 Ipsen S.A. Company Profile
11.7.2 Neuroendocrine Tumor Drug Product Overview
11.7.3 Ipsen S.A. Neuroendocrine Tumor Drug Market Performance (2019-2024)
11.7.4 Ipsen S.A. Business Overview
11.7.5 Recent Developments and Plans
11.8 Jiangsu Hengrui Medicine Co. Ltd
11.8.1 Jiangsu Hengrui Medicine Co. Ltd Company Profile
11.8.2 Neuroendocrine Tumor Drug Product Overview
11.8.3 Jiangsu Hengrui Medicine Co. Ltd Neuroendocrine Tumor Drug Market Performance (2019-2024)
11.8.4 Jiangsu Hengrui Medicine Co. Ltd Business Overview
11.8.5 Recent Developments and Plans
11.9 Karyopharm Therapeutics Inc.
11.9.1 Karyopharm Therapeutics Inc. Company Profile
11.9.2 Neuroendocrine Tumor Drug Product Overview
11.9.3 Karyopharm Therapeutics Inc. Neuroendocrine Tumor Drug Market Performance (2019-2024)
11.9.4 Karyopharm Therapeutics Inc. Business Overview
11.9.5 Recent Developments and Plans
11.10 Lexicon Pharmaceuticals Inc.
11.10.1 Lexicon Pharmaceuticals Inc. Company Profile
11.10.2 Neuroendocrine Tumor Drug Product Overview
11.10.3 Lexicon Pharmaceuticals Inc. Neuroendocrine Tumor Drug Market Performance (2019-2024)
11.10.4 Lexicon Pharmaceuticals Inc. Business Overview
11.10.5 Recent Developments and Plans
11.11 Midatech Pharma Plc .
11.11.1 Midatech Pharma Plc . Company Profile
11.11.2 Neuroendocrine Tumor Drug Product Overview
11.11.3 Midatech Pharma Plc . Neuroendocrine Tumor Drug Market Performance (2019-2024)
11.11.4 Midatech Pharma Plc . Business Overview
11.11.5 Recent Developments and Plans
11.12 Millennium Pharmaceuticals Inc.
11.12.1 Millennium Pharmaceuticals Inc. Company Profile
11.12.2 Neuroendocrine Tumor Drug Product Overview
11.12.3 Millennium Pharmaceuticals Inc. Neuroendocrine Tumor Drug Market Performance (2019-2024)
11.12.4 Millennium Pharmaceuticals Inc. Business Overview
11.12.5 Recent Developments and Plans
11.13 MolMed S.p.A.
11.13.1 MolMed S.p.A. Company Profile
11.13.2 Neuroendocrine Tumor Drug Product Overview
11.13.3 MolMed S.p.A. Neuroendocrine Tumor Drug Market Performance (2019-2024)
11.13.4 MolMed S.p.A. Business Overview
11.13.5 Recent Developments and Plans
11.14 Northwest Biotherapeutics Inc.
11.14.1 Northwest Biotherapeutics Inc. Company Profile
11.14.2 Neuroendocrine Tumor Drug Product Overview
11.14.3 Northwest Biotherapeutics Inc. Neuroendocrine Tumor Drug Market Performance (2019-2024)
11.14.4 Northwest Biotherapeutics Inc. Business Overview
11.14.5 Recent Developments and Plans
12 Global Neuroendocrine Tumor Drug Forecast Market Insights by Type
12.1 Global Neuroendocrine Tumor Drug Revenue Market Forecast by Type (2024-2030)
13 Global Neuroendocrine Tumor Drug Forecast Market Insights by Application
13.1 Neuroendocrine Tumor Drug Revenue Market Forecast by Application (2024-2030)
14 Global Market Growth Forecast Insights
14.1 Global Neuroendocrine Tumor Drug Forecast Market Size (2024-2030)
14.2 Neuroendocrine Tumor Drug Growth Forecast Insights by Regions
14.2.1 Neuroendocrine Tumor Drug Revenue Forecast Market Size by Regions (2024-2030)
14.2.2 North America Neuroendocrine Tumor Drug Forecast Market Size (2024-2030)
14.2.3 Europe Neuroendocrine Tumor Drug Forecast Market Size (2024-2030)
14.2.4 Asia-Pacific Neuroendocrine Tumor Drug Forecast Market Size (2024-2030)
14.2.5 Latin America Neuroendocrine Tumor Drug Forecast Market Size (2024-2030)
14.2.6 Middle East & Africa Neuroendocrine Tumor Drug Forecast Market Size (2024-2030)
15 Methodology and Data Source
15.1 A Methodology
15.1.1 Research Process
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 B Data Source
15.2.1 Legal Disclaimer